Farther Finance Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $857K | Buy |
10,954
+2,146
| +24% | +$168K | 0.02% | 660 |
|
|
2025
Q1 | $633K | Buy |
8,808
+7,013
| +391% | +$504K | 0.02% | 677 |
|
|
2024
Q4 | $133K | Sell |
1,795
-1,286
| -42% | -$95.2K | ﹤0.01% | 1187 |
|
|
2024
Q3 | $203K | Sell |
3,081
-3,302
| -52% | -$218K | 0.01% | 984 |
|
|
2024
Q2 | $576K | Buy |
6,383
+4,947
| +344% | +$446K | 0.03% | 440 |
|
|
2024
Q1 | $135K | Buy |
1,436
+448
| +45% | +$42.2K | 0.01% | 841 |
|
|
2023
Q4 | $75.3K | Buy |
988
+255
| +35% | +$19.4K | 0.01% | 892 |
|
|
2023
Q3 | $50.8K | Buy |
733
+279
| +61% | +$19.3K | 0.01% | 767 |
|
|
2023
Q2 | $42.8K | Buy |
454
+44
| +11% | +$4.15K | 0.01% | 728 |
|
|
2023
Q1 | $33.9K | Buy |
410
+75
| +22% | +$6.21K | 0.01% | 727 |
|
|
2022
Q4 | $25K | Buy |
+335
| New | +$25K | 0.01% | 665 |
|